Design Therapeutics Sets IPO Offering Range
socalTECH
MARCH 23, 2021
Carlsbad-based Design Therapeutics, a company developing treatments for serious degenerative disorders, has set an expected IPO offering range of between $18.00 per share, the company said in a filing this week. The company has applied to list on the Nasdaq Global Market as DSGN. and $20.00 billion.
Let's personalize your content